Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 10—October 2013

Research

Antibody Responses against Pneumocystis jirovecii in Health Care Workers Over Time

Serena FongComments to Author , Kieran R. Daly, Renuka Tipirneni, Leah G. Jarlsberg, Kpandja Djawe, Judy V. Koch, Alexandra Swartzman, Brenna Roth, Peter D. Walzer, and Laurence Huang
Author affiliations: San Francisco General Hospital/University of California, San Francisco, San Francisco, California, USA (S. Fong, R. Tipirneni, L.G. Jarlsberg, A. Swartzman, B. Roth, L. Huang); Veterans Affairs Medical Center/University of Cincinnati, Cincinnati, Ohio, USA (K.R. Daly, K. Djawe, J.V. Koch, P.D. Walzer)

Main Article

Table 1

Characteristics of San Francisco General Hospital staff in a study of antibody responses to Pneumocystis jirovecii, San Francisco, California, USA, 2007–2009*

Characteristic Total no. (%), N = 115 Clinical, no. (%), n = 99 Nonclinical, no. (%), n = 16 p value
Demographic
Mean age ± SD, y 39.5 ± 12.1 39.0 ± 12.4 42.8 ± 9.7 0.25
Sex
F 66 (57.4) 56 (56.6) 10 (62.5) Ref
M 49 (42.6) 43 (43.4) 6 (37.5) 0.66
Race:
White/Caucasian 70 (60.9) 59 (59.6) 11 (68.8) Ref
Asian 30 (26.1) 28 (28.3) 2 (12.5) 0.14
Black/African American 3 (2.6) 2 (2.0) 1 (6.3) 0.32
Multiple/other 12 (10.4) 10 (10.1) 2 (12.5) 0.95
Ethnicity
Hispanic/Latino 17 (14.8) 13 (13.1) 4 (25.0) 0.25
Health condition
Ever smoked 39 (33.9) 31 (31.3) 8 (50.0) 0.14
Lung condition 19 (16.5) 14 (14.1) 5 (31.3) 0.14
Immune condition 8 (7.0) 4 (4.0) 4 (25.0) 0.01
Professional
Department/Division:
HIV/AIDS 52 (45.2) 44 (44.4) 8 (50.0) Ref
Pulmonary and Critical Care Medicine 30 (26.1) 27 (27.3) 3 (18.8) 0.49
Medicine 27 (23.5) 23 (23.2) 4 (25.0) 0.90
Other 6 (5.2) 5 (5.1) 1 (6.3) 0.81
Ever exposed to PCP patient 79 (68.7) 77 (77.8) 2 (12.5) <0.001

*Ref., reference category; PCP, Pneumocystis jirovecii pneumonia.

Main Article

TOP